|
Lecturer(s)
|
-
Urbánek Karel, doc. MUDr. Ph.D.
-
Matalová Petra, MUDr. Ph.D.
|
|
Course content
|
The subject will be taught through four workshops, thematically focused on the issues of pharmacology and clinical pharmacology of monoclonal antibodies, inhibitors of tyrosinkinases and hormone analogues introduced recently to use in internal medicine, hematooncology and oncology.
|
|
Learning activities and teaching methods
|
|
Lecture, Dialogic Lecture (Discussion, Dialog, Brainstorming), Work with Text (with Book, Textbook)
|
|
Learning outcomes
|
The aim of the course is to acquaint students with the latest developments in the field of biological and hormonal pharmacotherapy in internal medicine and oncology. The course is designed primarily for students who want to study during and after profiling in fields in which it has in recent years introduced biological and hormonal therapy.
Students will gain advanced knowledge of the general principles of modern biological and hormonal therapy and its clinical applications beyond the knowledge gained completing the course of basic pharmacology.
|
|
Prerequisites
|
To register for this course is required completion of the subject Pharmacology 1, Pharmacology 2 enlistment.
FAR/VCA13 and FAR/VCB11 and PFY/VCB12 and CJA/VCB21 and MIK/VCA12
|
|
Assessment methods and criteria
|
Student performance
Attendance at seminars, completion of the colloquium.
|
|
Recommended literature
|
-
Švihovec, J. a kol. (2018). Farmakologie. Praha:Grada.
|